Cite
HARVARD Citation
Moore, K. et al. (n.d.). Maintenance olaparib after platinum-based chemotherapy in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: efficacy by the timing of surgery and residual tumour status following upfront or interval cytoreductive surgery in the Phase III SOLO1 trial. International journal of gynecological cancer. pp. A14-A15. [Online].